SUMMARY HLA-DR antigens and autoantibodies to the nuclear or cytoplasmic antigens Ro/SSA, La/SSB, Sm, and RNP were determined in North American and Austrian patients with systemic lupus erythematosus (SLE). Analysis of the association of antibodies to these ribonucleic acid (RNA)-protein antigens with HLA-DR antigens showed that HLA-DR3 was related to the presence of anti-Ro/SSA or anti-La/SSB, or both. In contrast, anti-Sm or anti-RNP, or both were associated with HLA-DR4. HLA-DR5 was associated with absence of these autoantibodies. The data extend evidence for the complexity and heterogeneity of SLE. Moreover, they indicate that, in SLE, genes linked to those coding for HLA-DR antigens, are related to the specifity of autoantibody responses rather than to the primary immunological abnormalities of this disorder.
and related to HLA-DR antigens. This allowed for a detailed analysis of potential associations between the presence of MHC encoded antigens and the occurrence of particular types of precipitating antibodies. Patients were divided into four groups: (a) patients with anti-La (SSB), anti-Ro (SSA), or both (termed group I or 'anti-Ro/La'); (b) patients with anti-Sm, anti-RNP, or both (termed group II or 'antiSm/RNP'); (c) patients with anti-Ro and anti-Sm Analysis of the relation between antibodies to RNA-protein and HLA antigens showed that the association of HLA-DR3 with SLE in the total patient population was predominantly due to its increased frequency in one subgroup of patients, namely those with the autoantibodies anti-Ro/SSA and LaISSB. In contrast, DR3 frequencies were low in patients with anti-Sm or anti-RNP antibodies, or both, and, as stated above, were not significantly increased in patients without precipitating antibodies to RNA-nucleoprotein antigens. Thus HLA-DR3 apparently does not represent a gene that predisposes to the disease in general but rather to a subset of the disease characterised by the production of a specific autoantibody. This interpretation is indirectly strengthened by the known relationship between HLA-DR3 and primary sicca syndrome,32-36 in which anti-Ro/SSA is also a serological hallmark.' 2 18 Moreover, it agrees with previous observations of the occurrence of HLA-DR3 and anti-Ro/SSA in SLE' 11 34 37-39 and LE subsets with characteristic clinical features associated with the presence of anti-Ro/SSA.10-'3 When comparing our data with those of these other studies, the important common determinator is the association of anti-Ro/La with HLA-DR3, which has previously been observed in both SLE37-39 and primary Sjogren's syndrome.3136 We could not find the previously reported38 39 association of anti-Ro with HLA-DR2. Moreover, in contrast with these authors, and as already previously reported by the University of Vienna and NIH groups separately,20 22 the present common study again confirms the highly increased frequency of HLA-DR3 in a much larger SLE population. Finallzy, in contrast with the findings of Alvarellos et al,3 our study showed no association of HLA-DR antigens with either frequency or levels of antinative DNA antibodies (data not shown). In additional analyses the presence of anti-Sm or RNP, or both, has been found to be significantly associated with HLA-DR4 and somewhat more strongly with the presence of DR4 or DR1, or both. Although this finding should not be overemphasised, these data and the low frequency of HLA-DR3 in this group of patients, which was also noted by Alvarellos et al,39 indicate that the expression of anti-Sm/RNP is genetically distinctly different from that of anti-Ro/La. According to our observations, patients having antibodies to both Ro and Sm/RNP tended to be positive for the DR antigens associated with each antibody specificity separately, namely DR3 and/or DR4 or DR1. It is of particular interest that the molecular structures of the related antigens Ro and La differ from the structures of the related antigens Sm and RNP, and that-as also seen in this study-anti-La almost always occurs together with anti-Ro, whereas anti-Sm very often is accompanied by anti-RNP.3 4 
